106 related articles for article (PubMed ID: 9819188)
21. Relationships between biomarkers and left ventricular filling pressures at rest and during exercise in patients after myocardial infarction.
Andersen MJ; Ersbøll M; Bro-Jeppesen J; Møller JE; Hassager C; Køber L; Borlaug BA; Goetze JP; Gustafsson F
J Card Fail; 2014 Dec; 20(12):959-67. PubMed ID: 25285749
[TBL] [Abstract][Full Text] [Related]
22. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
[TBL] [Abstract][Full Text] [Related]
23. Atrial natriuretic peptide vs. N-terminal-pro-atrial natriuretic peptide for the detection of left atrial dilatation in horses.
van der Vekens N; Decloedt A; de Clercq D; Ven S; Sys S; van Loon G
Equine Vet J; 2016 Jan; 48(1):15-20. PubMed ID: 25257480
[TBL] [Abstract][Full Text] [Related]
24. N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function.
Andersson B; Hall C
J Card Fail; 2000 Sep; 6(3):208-13. PubMed ID: 10997746
[TBL] [Abstract][Full Text] [Related]
25. Atrial plasma ANP and NH2-terminal proANP during right atrial pressure increase in humans.
Arjamaa O; Karlqvist K; Vainionpää V; Leppäluoto J; Vuolteenaho O
Acta Physiol Scand; 1996 Aug; 157(4):481-5. PubMed ID: 8869731
[TBL] [Abstract][Full Text] [Related]
26. Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP.
Gegenhuber A; Struck J; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
Clin Chem; 2006 May; 52(5):827-31. PubMed ID: 16543387
[TBL] [Abstract][Full Text] [Related]
27. An experimental study of cardiac natriuretic peptides as markers of development of congestive heart failure.
Klinge R; Hystad M; Kjekshus J; Karlberg BE; Djøseland O; Aakvaag A; Hall C
Scand J Clin Lab Invest; 1998 Dec; 58(8):683-91. PubMed ID: 10088206
[TBL] [Abstract][Full Text] [Related]
28. Enzyme immunoassays for fragments (epitopes) of human proatrial natriuretic peptides.
Hartter E; Khalafpour S; Missbichler A; Hawa G; Woloszczuk W
Clin Chem Lab Med; 2000 Jan; 38(1):27-32. PubMed ID: 10774958
[TBL] [Abstract][Full Text] [Related]
29. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.
Omland T; Aakvaag A; Vik-Mo H
Heart; 1996 Sep; 76(3):232-7. PubMed ID: 8868981
[TBL] [Abstract][Full Text] [Related]
30. Associations of circulating natriuretic peptides with haemodynamics in precapillary pulmonary hypertension.
Kaiser R; Grotemeyer K; Lepper P; Stokes C; Bals R; Wilkens H
Respir Med; 2015 Sep; 109(9):1213-23. PubMed ID: 26194624
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function.
Otterstad JE; St John Sutton MG; Froeland GS; Holme I; Skjaerpe T; Hall C
Eur Heart J; 2002 Jul; 23(13):1011-20. PubMed ID: 12093053
[TBL] [Abstract][Full Text] [Related]
32. Single assay for amino-terminal fragments of cardiac A- and B-type natriuretic peptides.
Ala-Kopsala M; Ruskoaho H; Leppäluoto J; Seres L; Skoumal R; Toth M; Horkay F; Vuolteenaho O
Clin Chem; 2005 Apr; 51(4):708-18. PubMed ID: 15718490
[TBL] [Abstract][Full Text] [Related]
33. Natriuretic peptides in patients with aortic stenosis.
Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
[TBL] [Abstract][Full Text] [Related]
34. Cross-laboratory analytical validation of the cardiac biomarker NT-proANP in rat.
Vinken P; Reagan WJ; Rodriguez LA; Buck WR; Lai-Zhang J; Goeminne N; Barbacci G; Liu R; King NM; Engle SK; Colton H
J Pharmacol Toxicol Methods; 2016; 77():58-65. PubMed ID: 26516096
[TBL] [Abstract][Full Text] [Related]
35. Measurement of N-terminal proatrial natriuretic peptide in plasma of cats with and without cardiomyopathy.
Zimmering TM; Meneses F; Nolte IJ; Simon D
Am J Vet Res; 2009 Feb; 70(2):216-22. PubMed ID: 19231954
[TBL] [Abstract][Full Text] [Related]
36. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
[TBL] [Abstract][Full Text] [Related]
37. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections.
Müller B; Süess E; Schuetz P; Müller C; Bingisser R; Bergmann A; Stolz D; Tamm M; Morgenthaler NG; Christ-Crain M
J Intern Med; 2006 Dec; 260(6):568-76. PubMed ID: 17116008
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the association between plasma concentration of N-terminal proatrial natriuretic peptide and outcome in cats with cardiomyopathy.
Zimmering TM; Hungerbühler S; Meneses F; Nolte I; Simon D
J Am Vet Med Assoc; 2010 Sep; 237(6):665-72. PubMed ID: 20839988
[TBL] [Abstract][Full Text] [Related]
39. Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure.
Azizi C; Maistre G; Kalotka H; Isnard R; Barthélemy C; Masson F; Pham P; Pousset F; Eurin J; Lechat P; Komajda M; Carayon A
J Endocrinol; 1996 Jan; 148(1):51-7. PubMed ID: 8568471
[TBL] [Abstract][Full Text] [Related]
40. Cocaine increases circulating levels of atrial natriuretic peptide and pro atrial natriuretic peptide N-terminal fragment in conscious rats.
Pelkonen M; Luodonpää M; Vuolteenaho O; Pasanen M; Ruskoaho H
Eur J Pharmacol; 1996 May; 304(1-3):55-62. PubMed ID: 8813584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
